Takayasu Arteritis
What's New
Last Posted: May 31, 2024
- Anti-integrin ?v?6 antibody in Takayasu arteritis patients with or without ulcerative colitis.
Yuki Ishikawa, et al. Frontiers in immunology 2024 0 1387516 - Angiogenesis related genes in Takayasu Arteritis (TAK): robust association with Tag SNPs of IL-18 and FGF-2 in a South Asian Cohort.
Debashish Danda, et al. Journal of human genetics 2023 0 - Systemic review and meta-analysis of the association between interleukin-10 and Takayasu arteritis.
Hang Zhou, et al. International journal of rheumatic diseases 2023 0 - Association of Killer Cell Immunoglobulin-like Receptor (KIR) Genes and their HLA Ligands with Susceptibility to Takayasu Arteritis in the Iranian Population.
Beigmohammadi Fereshteh, et al. Iranian journal of allergy, asthma, and immunology 2023 0 (1) 25-33 - Single-Nucleotide Polymorphism of the MLX Gene Is Associated With Takayasu Arteritis.
Tamura Natsuko, et al. Circulation. Genomic and precision medicine 2018 0 (10) e002296 - Roles of cytotoxic lymphocytes and MIC/LILR families in pathophysiology of Takayasu arteritis.
Yoshifuji Hajime, et al. Inflammation and regeneration 2020 0 9 - Association between Takayasu arteritis and ischemic heart disease: a cohort study.
Versini Mathilde, et al. Mediterranean journal of rheumatology 2020 0 (3) 171-176 - HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
Kushimoto Kazuo, et al. Arthritis research & therapy 2021 0 (1) 238 - Comprehensive Analysis of the HLA Class I and the HLA Class II Alleles in Patients with Takayasu Arteritis: Relationship with Clinical Patterns and Prognosis.
Stojanovic Maja, et al. Iranian journal of immunology : IJI 2021 0 (4) 354-365 - Whole Exome Sequencing Revealed Variants That Predict Pulmonary Artery Involvement in Patients with Takayasu Arteritis.
Liu Lingyu, et al. Journal of inflammation research 2022 0 4817-4831 - Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study.
Ortiz-Fernández Lourdes, et al. American journal of human genetics 2020 0 (1) 84-99 - Polymorphisms of F2 (G20210A), F5 (G1691A), F 7 (G10976A), F 13(G13T), FGB, ITGA2, ITGB3, PAI-I genes and its association with thrombotic complications in patients suffering from Takayasu aortoarteritis of Urals population.
Borodina Irina, et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2021 9 (6) 448-455 - A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis.
Kadoba Keiichiro, et al. Scientific reports 2021 7 (1) 13667 - Polymorphisms in TNFAIP3, but not in STAT4, BANK1, BLK, and TNFSF4, are associated with susceptibility to Takayasu arteritis.
Montúfar-Robles Isela, et al. Cellular immunology 2021 5 104375 - Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.
Thomsen Hauke et al. Scientific reports 2020 10(1) 20887 - Association of interleukin-18 gene polymorphisms with Takayasu arteritis in a Chinese Han population.
Wen Dan, et al. Chinese medical journal 2020 8 - C-reactive protein gene polymorphisms (rs1205) in Asian Indian patients with Takayasu arteritis: Associations and phenotype correlations.
Nair Aswin M, et al. International journal of rheumatic diseases 2018 3 (3) 732-739 - Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.
Nair Aswin M, et al. Rheumatology international 2017 10 (10) 1643-1649 - Single nucleotide polymorphisms of IL12B are associated with Takayasu arteritis in Chinese Han population.
Wen Xiaoting, et al. Rheumatology international 2017 4 (4) 547-555 - Takayasu arteritis risk locus in IL6 represses the anti-inflammatory gene GPNMB through chromatin looping and recruiting MEF2-HDAC complex.
Kong Xiufang, et al. Annals of the rheumatic diseases 2019 7
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: